TUDOR INVESTMENT CORP ET AL - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$33,999
+3.5%
57,0830.0%0.00%
Q2 2023$32,834
+81985.0%
57,0830.0%0.00%
-100.0%
Q1 2023$40
-93.3%
57,083
-78.5%
0.00%
-91.7%
Q4 2022$601
-99.9%
265,827
-0.5%
0.01%
-33.3%
Q3 2022$855,000
-53.5%
267,063
-44.8%
0.02%
-62.5%
Q2 2022$1,838,000
-27.9%
483,788
+2.3%
0.05%
-20.0%
Q1 2022$2,548,000
+44.8%
472,688
+262.9%
0.06%
+106.9%
Q4 2021$1,760,000
+0.9%
130,266
+34.1%
0.03%
+3.6%
Q3 2021$1,744,000
-42.9%
97,113
-45.4%
0.03%
-51.7%
Q2 2021$3,052,000
+931.1%
177,859
+922.1%
0.06%
+625.0%
Q4 2020$296,000
-82.3%
17,401
-82.8%
0.01%
-89.0%
Q3 2020$1,675,000
-24.1%
100,972
+6.0%
0.07%
-33.0%
Q2 2020$2,207,000
+210.8%
95,287
+139.6%
0.11%
+70.3%
Q1 2020$710,000
-76.4%
39,774
-71.5%
0.06%
-52.6%
Q4 2019$3,012,000
+1176.3%
139,554
+979.1%
0.14%
+1587.5%
Q3 2019$236,000
-37.6%
12,932
+108.8%
0.01%
-20.0%
Q3 2018$378,000
-92.9%
6,193
-94.3%
0.01%
-94.6%
Q2 2018$5,326,000
+2733.0%
109,071
+696.1%
0.18%
+3600.0%
Q1 2016$188,000
+26.2%
13,700
+14.8%
0.01%
+25.0%
Q2 2015$149,000
-17.7%
11,933
+2.0%
0.00%
-33.3%
Q4 2014$181,00011,6980.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders